Loading...
•
Jun 28, 2025
Hologic Q3 2025 Earnings Report
Hologic reported its financial results for the third quarter of fiscal 2025, exceeding revenue and non-GAAP diluted EPS guidance.
Key Takeaways
Hologic delivered a solid third quarter in fiscal 2025, with revenue of $1,023.8 million and non-GAAP diluted EPS of $1.08, both surpassing guidance. The company saw growth in Diagnostics and Surgical segments, with a continued rebound in Breast Health expected to drive future growth.
Revenue reached $1,023.8 million, exceeding the company's guidance range.
Non-GAAP diluted EPS was $1.08, surpassing the high end of the guidance range.
Diagnostics revenue increased by 1.8%, driven by molecular diagnostics sales.
Surgical revenue grew by 7.1%, primarily due to the acquired Gynesonics business and strong international sales.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Hologic expects continued mid-single-digit growth in organic, constant currency revenue excluding COVID-19 for the fourth quarter, with non-GAAP EPS growing faster than revenue.
Positive Outlook
- Expected mid-single-digit growth in organic, constant currency revenue excluding COVID-19 for Q4 2025.
- Non-GAAP EPS is forecast to grow faster than revenue in Q4 2025.
- Tariff mitigation efforts are expected to help non-GAAP EPS growth.
- Full year fiscal 2025 revenue guidance of $4,081 million to $4,091 million.
- Full year fiscal 2025 non-GAAP EPS guidance of $4.23 to $4.26.
Challenges Ahead
- GAAP EPS for full fiscal 2025 is projected to decrease by 22.9% to 22.0% compared to the previous year.
- The acquired Gynesonics business revenue will be excluded from organic revenue for all of fiscal 2025.
- No specific negative impacts were highlighted for the upcoming quarter beyond the GAAP EPS decline.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...